APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Metoclopramide

Compare research editions
View pricing & licenses

Selected research

Industry Research

Metoclopramide Industry Research Report 2026

Report ID 174013030519 December 2025146 pages

Choose your research edition.

Industry ResearchMetoclopramide Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Metoclopramide Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Metoclopramide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metoclopramide Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Metoclopramide Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Metoclopramide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Metoclopramide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Metoclopramide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Metoclopramide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Metoclopramide include Adwya, Alkaloid Pharmaceuticals, Amneal Pharmaceuticals, Apotex, ASKA Seiyaku Asuka, Astellas, Biofarma, Ceva Sante Animale and EU-Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Metoclopramide market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Metoclopramide Market by Company

Adwya

Alkaloid Pharmaceuticals

Amneal Pharmaceuticals

Apotex

ASKA Seiyaku Asuka

Astellas

Biofarma

Ceva Sante Animale

EU-Pharma

Le Vet

Meda Pharma

Nidda

Omega Laboratories

Orion Pharma

Teuto Brasileiro

Wockhardt

Yang Sheng

GSK

Pfizer

Mylan

Novartis

Johnson and Johnson

Sanofi

Teva

Metoclopramide Segment by Type

Oral

Injection

Metoclopramide Segment by Application

Nausea

Migraine

Gastroparesis

Metoclopramide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metoclopramide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metoclopramide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metoclopramide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Metoclopramide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Metoclopramide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Metoclopramide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Metoclopramide Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Metoclopramide Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Metoclopramide Sales Market Share by Manufacturers (2021-2026) Table 8. Global Metoclopramide Revenue of Manufacturers (2021-2026) Table 9. Global Metoclopramide Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Metoclopramide Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Metoclopramide Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Metoclopramide, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Metoclopramide, Product Type & Application Table 14. Global Metoclopramide Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Metoclopramide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Adwya Company Information Table 19. Adwya Business Overview Table 20. Adwya Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Adwya Metoclopramide Product Portfolio Table 22. Adwya Recent Developments Table 23. Alkaloid Pharmaceuticals Company Information Table 24. Alkaloid Pharmaceuticals Business Overview Table 25. Alkaloid Pharmaceuticals Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Alkaloid Pharmaceuticals Metoclopramide Product Portfolio Table 27. Alkaloid Pharmaceuticals Recent Developments Table 28. Amneal Pharmaceuticals Company Information Table 29. Amneal Pharmaceuticals Business Overview Table 30. Amneal Pharmaceuticals Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Amneal Pharmaceuticals Metoclopramide Product Portfolio Table 32. Amneal Pharmaceuticals Recent Developments Table 33. Apotex Company Information Table 34. Apotex Business Overview Table 35. Apotex Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Apotex Metoclopramide Product Portfolio Table 37. Apotex Recent Developments Table 38. ASKA Seiyaku Asuka Company Information Table 39. ASKA Seiyaku Asuka Business Overview Table 40. ASKA Seiyaku Asuka Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. ASKA Seiyaku Asuka Metoclopramide Product Portfolio Table 42. ASKA Seiyaku Asuka Recent Developments Table 43. Astellas Company Information Table 44. Astellas Business Overview Table 45. Astellas Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Astellas Metoclopramide Product Portfolio Table 47. Astellas Recent Developments Table 48. Biofarma Company Information Table 49. Biofarma Business Overview Table 50. Biofarma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Biofarma Metoclopramide Product Portfolio Table 52. Biofarma Recent Developments Table 53. Ceva Sante Animale Company Information Table 54. Ceva Sante Animale Business Overview Table 55. Ceva Sante Animale Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Ceva Sante Animale Metoclopramide Product Portfolio Table 57. Ceva Sante Animale Recent Developments Table 58. EU-Pharma Company Information Table 59. EU-Pharma Business Overview Table 60. EU-Pharma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. EU-Pharma Metoclopramide Product Portfolio Table 62. EU-Pharma Recent Developments Table 63. Le Vet Company Information Table 64. Le Vet Business Overview Table 65. Le Vet Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Le Vet Metoclopramide Product Portfolio Table 67. Le Vet Recent Developments Table 68. Meda Pharma Company Information Table 69. Meda Pharma Business Overview Table 70. Meda Pharma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Meda Pharma Metoclopramide Product Portfolio Table 72. Meda Pharma Recent Developments Table 73. Nidda Company Information Table 74. Nidda Business Overview Table 75. Nidda Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Nidda Metoclopramide Product Portfolio Table 77. Nidda Recent Developments Table 78. Omega Laboratories Company Information Table 79. Omega Laboratories Business Overview Table 80. Omega Laboratories Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Omega Laboratories Metoclopramide Product Portfolio Table 82. Omega Laboratories Recent Developments Table 83. Orion Pharma Company Information Table 84. Orion Pharma Business Overview Table 85. Orion Pharma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Orion Pharma Metoclopramide Product Portfolio Table 87. Orion Pharma Recent Developments Table 88. Teuto Brasileiro Company Information Table 89. Teuto Brasileiro Business Overview Table 90. Teuto Brasileiro Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Teuto Brasileiro Metoclopramide Product Portfolio Table 92. Teuto Brasileiro Recent Developments Table 93. Wockhardt Company Information Table 94. Wockhardt Business Overview Table 95. Wockhardt Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Wockhardt Metoclopramide Product Portfolio Table 97. Wockhardt Recent Developments Table 98. Yang Sheng Company Information Table 99. Yang Sheng Business Overview Table 100. Yang Sheng Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Yang Sheng Metoclopramide Product Portfolio Table 102. Yang Sheng Recent Developments Table 103. GSK Company Information Table 104. GSK Business Overview Table 105. GSK Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. GSK Metoclopramide Product Portfolio Table 107. GSK Recent Developments Table 108. Pfizer Company Information Table 109. Pfizer Business Overview Table 110. Pfizer Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Pfizer Metoclopramide Product Portfolio Table 112. Pfizer Recent Developments Table 113. Mylan Company Information Table 114. Mylan Business Overview Table 115. Mylan Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Mylan Metoclopramide Product Portfolio Table 117. Mylan Recent Developments Table 118. Novartis Company Information Table 119. Novartis Business Overview Table 120. Novartis Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Novartis Metoclopramide Product Portfolio Table 122. Novartis Recent Developments Table 123. Johnson and Johnson Company Information Table 124. Johnson and Johnson Business Overview Table 125. Johnson and Johnson Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Johnson and Johnson Metoclopramide Product Portfolio Table 127. Johnson and Johnson Recent Developments Table 128. Sanofi Company Information Table 129. Sanofi Business Overview Table 130. Sanofi Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Sanofi Metoclopramide Product Portfolio Table 132. Sanofi Recent Developments Table 133. Teva Company Information Table 134. Teva Business Overview Table 135. Teva Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Teva Metoclopramide Product Portfolio Table 137. Teva Recent Developments Table 138. Global Metoclopramide Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 139. Global Metoclopramide Sales by Region (2021-2026) & (K Units) Table 140. Global Metoclopramide Sales Market Share by Region (2021-2026) Table 141. Global Metoclopramide Sales by Region (2027-2032) & (K Units) Table 142. Global Metoclopramide Sales Market Share by Region (2027-2032) Table 143. Global Metoclopramide Revenue by Region (2021-2026) & (US$ Million) Table 144. Global Metoclopramide Revenue Market Share by Region (2021-2026) Table 145. Global Metoclopramide Revenue by Region (2027-2032) & (US$ Million) Table 146. Global Metoclopramide Revenue Market Share by Region (2027-2032) Table 147. North America Metoclopramide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. North America Metoclopramide Sales by Country (2021-2026) & (K Units) Table 149. North America Metoclopramide Sales by Country (2027-2032) & (K Units) Table 150. North America Metoclopramide Revenue by Country (2021-2026) & (US$ Million) Table 151. North America Metoclopramide Revenue by Country (2027-2032) & (US$ Million) Table 152. Europe Metoclopramide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Europe Metoclopramide Sales by Country (2021-2026) & (K Units) Table 154. Europe Metoclopramide Sales by Country (2027-2032) & (K Units) Table 155. Europe Metoclopramide Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe Metoclopramide Revenue by Country (2027-2032) & (US$ Million) Table 157. Asia Pacific Metoclopramide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Asia Pacific Metoclopramide Sales by Country (2021-2026) & (K Units) Table 159. Asia Pacific Metoclopramide Sales by Country (2027-2032) & (K Units) Table 160. Asia Pacific Metoclopramide Revenue by Country (2021-2026) & (US$ Million) Table 161. Asia Pacific Metoclopramide Revenue by Country (2027-2032) & (US$ Million) Table 162. South America Metoclopramide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. South America Metoclopramide Sales by Country (2021-2026) & (K Units) Table 164. South America Metoclopramide Sales by Country (2027-2032) & (K Units) Table 165. South America Metoclopramide Revenue by Country (2021-2026) & (US$ Million) Table 166. South America Metoclopramide Revenue by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Metoclopramide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Middle East and Africa Metoclopramide Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Metoclopramide Sales by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Metoclopramide Revenue by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Metoclopramide Revenue by Country (2027-2032) & (US$ Million) Table 172. Global Metoclopramide Sales by Type (2021-2026) & (K Units) Table 173. Global Metoclopramide Sales by Type (2027-2032) & (K Units) Table 174. Global Metoclopramide Sales Market Share by Type (2021-2026) Table 175. Global Metoclopramide Sales Market Share by Type (2027-2032) Table 176. Global Metoclopramide Revenue by Type (2021-2026) & (US$ Million) Table 177. Global Metoclopramide Revenue by Type (2027-2032) & (US$ Million) Table 178. Global Metoclopramide Revenue Market Share by Type (2021-2026) Table 179. Global Metoclopramide Revenue Market Share by Type (2027-2032) Table 180. Global Metoclopramide Price by Type (2021-2026) & (US$/Unit) Table 181. Global Metoclopramide Price by Type (2027-2032) & (US$/Unit) Table 182. Global Metoclopramide Sales by Application (2021-2026) & (K Units) Table 183. Global Metoclopramide Sales by Application (2027-2032) & (K Units) Table 184. Global Metoclopramide Sales Market Share by Application (2021-2026) Table 185. Global Metoclopramide Sales Market Share by Application (2027-2032) Table 186. Global Metoclopramide Revenue by Application (2021-2026) & (US$ Million) Table 187. Global Metoclopramide Revenue by Application (2027-2032) & (US$ Million) Table 188. Global Metoclopramide Revenue Market Share by Application (2021-2026) Table 189. Global Metoclopramide Revenue Market Share by Application (2027-2032) Table 190. Global Metoclopramide Price by Application (2021-2026) & (US$/Unit) Table 191. Global Metoclopramide Price by Application (2027-2032) & (US$/Unit) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Metoclopramide Distributors List Table 195. Metoclopramide Customers List Table 196. Metoclopramide Industry Trends Table 197. Metoclopramide Industry Drivers Table 198. Metoclopramide Industry Restraints Table 199. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Metoclopramide Product Image Figure 5. Global Metoclopramide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Metoclopramide Market Size (2021-2032) & (US$ Million) Figure 7. Global Metoclopramide Sales (2021-2032) & (K Units) Figure 8. Global Metoclopramide Average Price (US$/Unit) & (2021-2032) Figure 9. Oral Product Image Figure 10. Injection Product Image Figure 11. Nausea Product Image Figure 12. Migraine Product Image Figure 13. Gastroparesis Product Image Figure 14. Global Metoclopramide Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Metoclopramide, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Metoclopramide Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Metoclopramide Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Metoclopramide Sales by Region in 2025 Figure 20. Global Metoclopramide Revenue by Region in 2025 Figure 21. North America Metoclopramide Market Size by Country in 2025 Figure 22. North America Metoclopramide Sales Market Share by Country (2021-2032) Figure 23. North America Metoclopramide Revenue Market Share by Country (2021-2032) Figure 24. United States Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Metoclopramide Market Size by Country in 2025 Figure 27. Europe Metoclopramide Sales Market Share by Country (2021-2032) Figure 28. Europe Metoclopramide Revenue Market Share by Country (2021-2032) Figure 29. Germany Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Asia Pacific Metoclopramide Market Size by Country in 2025 Figure 35. Asia Pacific Metoclopramide Sales Market Share by Country (2021-2032) Figure 36. Asia Pacific Metoclopramide Revenue Market Share by Country (2021-2032) Figure 37. China Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Japan Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. South Korea Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. India Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Australia Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. China Taiwan Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South America Metoclopramide Market Size by Country in 2025 Figure 46. South America Metoclopramide Sales Market Share by Country (2021-2032) Figure 47. South America Metoclopramide Revenue Market Share by Country (2021-2032) Figure 48. Mexico Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Brazil Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Argentina Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Colombia Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa Metoclopramide Market Size by Country in 2025 Figure 53. Middle East and Africa Metoclopramide Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa Metoclopramide Revenue Market Share by Country (2021-2032) Figure 55. Turkey Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE Metoclopramide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global Metoclopramide Sales Market Share by Type (2021-2032) Figure 59. Global Metoclopramide Revenue Market Share by Type (2021-2032) Figure 60. Global Metoclopramide Price (US$/Unit) by Type (2021-2032) Figure 61. Global Metoclopramide Sales Market Share by Application (2021-2032) Figure 62. Global Metoclopramide Revenue Market Share by Application (2021-2032) Figure 63. Global Metoclopramide Price (US$/Unit) by Application (2021-2032) Figure 64. Metoclopramide Value Chain Figure 65. Metoclopramide Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Metoclopramide Industry Opportunities and Challenges

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Nausea
  • Migraine
  • Gastroparesis
Companies covered
  • Adwya
  • Alkaloid Pharmaceuticals
  • Amneal Pharmaceuticals
  • Apotex
  • ASKA Seiyaku Asuka
  • Astellas
  • Biofarma
  • Ceva Sante Animale
  • EU-Pharma
  • Le Vet
  • Meda Pharma
  • Nidda
  • Omega Laboratories
  • Orion Pharma
  • Teuto Brasileiro
  • Wockhardt
  • Yang Sheng
  • GSK
  • Pfizer
  • Mylan
  • Novartis
  • Johnson and Johnson
  • Sanofi
  • Teva

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Metoclopramide Market Size (2021-2032)
  4. 2.2.2 Global Metoclopramide Sales (2021-2032)
  5. 2.2.3 Global Metoclopramide Market Average Price (2021-2032)
  6. 2.3 Metoclopramide by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Oral
  9. 2.3.3 Injection
  10. 2.4 Metoclopramide by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Nausea
  13. 2.4.3 Migraine
  14. 2.4.4 Gastroparesis
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Metoclopramide Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Metoclopramide Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Metoclopramide Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Metoclopramide Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Metoclopramide Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Metoclopramide, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Metoclopramide, Product Type & Application
  8. 3.8 Global Manufacturers of Metoclopramide, Established Date
  9. 3.9 Global Metoclopramide Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Adwya
  2. 4.1.1 Adwya Company Information
  3. 4.1.2 Adwya Business Overview
  4. 4.1.3 Adwya Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Adwya Metoclopramide Product Portfolio
  6. 4.1.5 Adwya Recent Developments
  7. 4.2 Alkaloid Pharmaceuticals
  8. 4.2.1 Alkaloid Pharmaceuticals Company Information
  9. 4.2.2 Alkaloid Pharmaceuticals Business Overview
  10. 4.2.3 Alkaloid Pharmaceuticals Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Alkaloid Pharmaceuticals Metoclopramide Product Portfolio
  12. 4.2.5 Alkaloid Pharmaceuticals Recent Developments
  13. 4.3 Amneal Pharmaceuticals
  14. 4.3.1 Amneal Pharmaceuticals Company Information
  15. 4.3.2 Amneal Pharmaceuticals Business Overview
  16. 4.3.3 Amneal Pharmaceuticals Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Amneal Pharmaceuticals Metoclopramide Product Portfolio
  18. 4.3.5 Amneal Pharmaceuticals Recent Developments
  19. 4.4 Apotex
  20. 4.4.1 Apotex Company Information
  21. 4.4.2 Apotex Business Overview
  22. 4.4.3 Apotex Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Apotex Metoclopramide Product Portfolio
  24. 4.4.5 Apotex Recent Developments
  25. 4.5 ASKA Seiyaku Asuka
  26. 4.5.1 ASKA Seiyaku Asuka Company Information
  27. 4.5.2 ASKA Seiyaku Asuka Business Overview
  28. 4.5.3 ASKA Seiyaku Asuka Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 ASKA Seiyaku Asuka Metoclopramide Product Portfolio
  30. 4.5.5 ASKA Seiyaku Asuka Recent Developments
  31. 4.6 Astellas
  32. 4.6.1 Astellas Company Information
  33. 4.6.2 Astellas Business Overview
  34. 4.6.3 Astellas Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Astellas Metoclopramide Product Portfolio
  36. 4.6.5 Astellas Recent Developments
  37. 4.7 Biofarma
  38. 4.7.1 Biofarma Company Information
  39. 4.7.2 Biofarma Business Overview
  40. 4.7.3 Biofarma Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Biofarma Metoclopramide Product Portfolio
  42. 4.7.5 Biofarma Recent Developments
  43. 4.8 Ceva Sante Animale
  44. 4.8.1 Ceva Sante Animale Company Information
  45. 4.8.2 Ceva Sante Animale Business Overview
  46. 4.8.3 Ceva Sante Animale Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Ceva Sante Animale Metoclopramide Product Portfolio
  48. 4.8.5 Ceva Sante Animale Recent Developments
  49. 4.9 EU-Pharma
  50. 4.9.1 EU-Pharma Company Information
  51. 4.9.2 EU-Pharma Business Overview
  52. 4.9.3 EU-Pharma Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 EU-Pharma Metoclopramide Product Portfolio
  54. 4.9.5 EU-Pharma Recent Developments
  55. 4.10 Le Vet
  56. 4.10.1 Le Vet Company Information
  57. 4.10.2 Le Vet Business Overview
  58. 4.10.3 Le Vet Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Le Vet Metoclopramide Product Portfolio
  60. 4.10.5 Le Vet Recent Developments
  61. 4.11 Meda Pharma
  62. 4.11.1 Meda Pharma Company Information
  63. 4.11.2 Meda Pharma Business Overview
  64. 4.11.3 Meda Pharma Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Meda Pharma Metoclopramide Product Portfolio
  66. 4.11.5 Meda Pharma Recent Developments
  67. 4.12 Nidda
  68. 4.12.1 Nidda Company Information
  69. 4.12.2 Nidda Business Overview
  70. 4.12.3 Nidda Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Nidda Metoclopramide Product Portfolio
  72. 4.12.5 Nidda Recent Developments
  73. 4.13 Omega Laboratories
  74. 4.13.1 Omega Laboratories Company Information
  75. 4.13.2 Omega Laboratories Business Overview
  76. 4.13.3 Omega Laboratories Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Omega Laboratories Metoclopramide Product Portfolio
  78. 4.13.5 Omega Laboratories Recent Developments
  79. 4.14 Orion Pharma
  80. 4.14.1 Orion Pharma Company Information
  81. 4.14.2 Orion Pharma Business Overview
  82. 4.14.3 Orion Pharma Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Orion Pharma Metoclopramide Product Portfolio
  84. 4.14.5 Orion Pharma Recent Developments
  85. 4.15 Teuto Brasileiro
  86. 4.15.1 Teuto Brasileiro Company Information
  87. 4.15.2 Teuto Brasileiro Business Overview
  88. 4.15.3 Teuto Brasileiro Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Teuto Brasileiro Metoclopramide Product Portfolio
  90. 4.15.5 Teuto Brasileiro Recent Developments
  91. 4.16 Wockhardt
  92. 4.16.1 Wockhardt Company Information
  93. 4.16.2 Wockhardt Business Overview
  94. 4.16.3 Wockhardt Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Wockhardt Metoclopramide Product Portfolio
  96. 4.16.5 Wockhardt Recent Developments
  97. 4.17 Yang Sheng
  98. 4.17.1 Yang Sheng Company Information
  99. 4.17.2 Yang Sheng Business Overview
  100. 4.17.3 Yang Sheng Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Yang Sheng Metoclopramide Product Portfolio
  102. 4.17.5 Yang Sheng Recent Developments
  103. 4.18 GSK
  104. 4.18.1 GSK Company Information
  105. 4.18.2 GSK Business Overview
  106. 4.18.3 GSK Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 GSK Metoclopramide Product Portfolio
  108. 4.18.5 GSK Recent Developments
  109. 4.19 Pfizer
  110. 4.19.1 Pfizer Company Information
  111. 4.19.2 Pfizer Business Overview
  112. 4.19.3 Pfizer Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Pfizer Metoclopramide Product Portfolio
  114. 4.19.5 Pfizer Recent Developments
  115. 4.20 Mylan
  116. 4.20.1 Mylan Company Information
  117. 4.20.2 Mylan Business Overview
  118. 4.20.3 Mylan Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Mylan Metoclopramide Product Portfolio
  120. 4.20.5 Mylan Recent Developments
  121. 4.21 Novartis
  122. 4.21.1 Novartis Company Information
  123. 4.21.2 Novartis Business Overview
  124. 4.21.3 Novartis Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Novartis Metoclopramide Product Portfolio
  126. 4.21.5 Novartis Recent Developments
  127. 4.22 Johnson and Johnson
  128. 4.22.1 Johnson and Johnson Company Information
  129. 4.22.2 Johnson and Johnson Business Overview
  130. 4.22.3 Johnson and Johnson Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Johnson and Johnson Metoclopramide Product Portfolio
  132. 4.22.5 Johnson and Johnson Recent Developments
  133. 4.23 Sanofi
  134. 4.23.1 Sanofi Company Information
  135. 4.23.2 Sanofi Business Overview
  136. 4.23.3 Sanofi Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Sanofi Metoclopramide Product Portfolio
  138. 4.23.5 Sanofi Recent Developments
  139. 4.24 Teva
  140. 4.24.1 Teva Company Information
  141. 4.24.2 Teva Business Overview
  142. 4.24.3 Teva Metoclopramide Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Teva Metoclopramide Product Portfolio
  144. 4.24.5 Teva Recent Developments
5 Global Metoclopramide Market Scenario by Region
  1. 5.1 Global Metoclopramide Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Metoclopramide Sales by Region: 2021-2032
  3. 5.2.1 Global Metoclopramide Sales by Region: 2021-2026
  4. 5.2.2 Global Metoclopramide Sales by Region: 2027-2032
  5. 5.3 Global Metoclopramide Revenue by Region: 2021-2032
  6. 5.3.1 Global Metoclopramide Revenue by Region: 2021-2026
  7. 5.3.2 Global Metoclopramide Revenue by Region: 2027-2032
  8. 5.4 North America Metoclopramide Market Facts & Figures by Country
  9. 5.4.1 North America Metoclopramide Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Metoclopramide Sales by Country (2021-2032)
  11. 5.4.3 North America Metoclopramide Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Metoclopramide Market Facts & Figures by Country
  15. 5.5.1 Europe Metoclopramide Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Metoclopramide Sales by Country (2021-2032)
  17. 5.5.3 Europe Metoclopramide Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Metoclopramide Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Metoclopramide Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Metoclopramide Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Metoclopramide Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Metoclopramide Market Facts & Figures by Country
  35. 5.7.1 South America Metoclopramide Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Metoclopramide Sales by Country (2021-2032)
  37. 5.7.3 South America Metoclopramide Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.7.7 Colombia
  42. 5.8 Middle East and Africa Metoclopramide Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Metoclopramide Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Metoclopramide Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Metoclopramide Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Metoclopramide Sales by Type (2021-2032)
  2. 6.1.1 Global Metoclopramide Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Metoclopramide Sales Market Share by Type (2021-2032)
  4. 6.2 Global Metoclopramide Revenue by Type (2021-2032)
  5. 6.2.1 Global Metoclopramide Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Metoclopramide Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Metoclopramide Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Metoclopramide Sales by Application (2021-2032)
  2. 7.1.1 Global Metoclopramide Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Metoclopramide Sales Market Share by Application (2021-2032)
  4. 7.2 Global Metoclopramide Revenue by Application (2021-2032)
  5. 7.2.1 Global Metoclopramide Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Metoclopramide Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Metoclopramide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Metoclopramide Value Chain Analysis
  2. 8.1.1 Metoclopramide Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Metoclopramide Production Mode & Process
  5. 8.2 Metoclopramide Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Metoclopramide Distributors
  8. 8.2.3 Metoclopramide Customers
9 Global Metoclopramide Analyzing Market Dynamics
  1. 9.1 Metoclopramide Industry Trends
  2. 9.2 Metoclopramide Industry Drivers
  3. 9.3 Metoclopramide Industry Opportunities and Challenges
  4. 9.4 Metoclopramide Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst